Polycystic Ovary Syndrome (PCOS)

Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously known as Polycystic Ovary Syndrome (PCOS), is one of the most common hormonal conditions I see in my female bariatric patients, and one of the most life-altering. It affects not just fertility, but a woman's entire hormonal health, metabolic function, physical appearance, emotional wellbeing, and quality of life. What makes PMOS particularly frustrating for the women who live with it is that it is so deeply intertwined with weight — obesity makes PMOS worse, and PMOS makes obesity worse, creating a vicious cycle that can feel nearly impossible to break without significant intervention. Bariatric surgery offers a powerful and proven way to interrupt that cycle — and the results my patients experience are often nothing short of transformative. This is a topic I feel deeply passionate about, and one every woman with PMOS and obesity deserves to fully understand.

What Is PMOS?

Polyendocrine Metabolic Ovarian Syndrome is a complex hormonal disorder that affects approximately 8 to 13% of women of reproductive age — making it the most common endocrine disorder in women worldwide. Despite its name, not all women with PCOS / PMOS actually have cysts on their ovaries — the name refers to the appearance of multiple small follicles on ultrasound that represent eggs that never fully developed or were released.

PMOS is diagnosed based on the presence of at least two of the following three criteria — known as the Rotterdam criteria:

• Irregular or absent menstrual periods — reflecting disordered or absent ovulation
• Hyperandrogenism — elevated levels of male hormones (androgens) such as testosterone, either measured in the blood or manifesting as clinical symptoms like excess facial or body hair, acne, or scalp hair thinning
• Polycystic ovarian morphology — the characteristic appearance of multiple small follicles on ovarian ultrasound

But PMOS is far more than just a reproductive condition. It is a systemic metabolic disorder with wide-ranging effects throughout the entire body, including:

• Insulin resistance — present in 65 to 80% of women with PMOS, regardless of weight, and a central driver of most of the condition's features
• Type 2 diabetes and prediabetes — women with PMOS have a 5 to 10 times higher lifetime risk of developing type 2 diabetes
• Metabolic syndrome — the dangerous cluster of high blood pressure, abnormal cholesterol, insulin resistance, and abdominal obesity
• Cardiovascular disease — PMOS significantly increases the long-term risk of heart disease and stroke
• Non-alcoholic fatty liver disease — strongly associated with the insulin resistance and metabolic dysfunction of PMOS
• Endometrial cancer — chronic absence of ovulation leads to unopposed estrogen stimulation of the uterine lining, dramatically increasing the risk of endometrial hyperplasia and cancer
• Obstructive sleep apnea — significantly more common in women with PMOS than in the general female population
• Depression and anxiety — affecting up to 40 to 50% of women with PMOS, driven by hormonal dysregulation, body image concerns, infertility struggles, and the chronic nature of the condition
• Infertility — PMOS is the single most common cause of anovulatory infertility in women worldwide

The Relationship Between PMOS and Obesity — A Vicious Cycle

The relationship between PMOS and obesity is one of the most frustrating and clinically important aspects of this condition — and it is something I discuss at length with every PMOS patient I evaluate for bariatric surgery.

Obesity does not cause PMOS — women of normal weight can and do develop PMOS. However, excess weight dramatically amplifies every aspect of PMOS through a set of interconnected mechanisms that create a self-reinforcing downward spiral:

How Obesity Worsens PMOS:

• Amplified insulin resistance — excess body fat, particularly visceral fat, dramatically worsens insulin resistance. Since insulin resistance is already a central feature of PMOS, obesity pours fuel on an already burning fire — driving higher insulin levels, greater androgen production, more disordered ovulation, and worsening metabolic dysfunction
• Increased androgen production — excess insulin directly stimulates the ovaries and adrenal glands to produce more androgens — male hormones that disrupt ovulation, cause hirsutism, acne, and scalp hair loss, and worsen virtually every aspect of PMOS
• Disrupted sex hormone binding globulin (SHBG) — obesity suppresses hepatic production of SHBG, the protein that binds and inactivates testosterone in the bloodstream. Lower SHBG means more free, biologically active testosterone circulating — amplifying androgenic symptoms
• Altered adipokine production — excess fat tissue produces elevated leptin and reduced adiponectin, both of which further impair ovarian function, worsen insulin resistance, and promote systemic inflammation
• Chronic inflammation — the pro-inflammatory state driven by excess visceral fat directly impairs ovarian function and hormonal regulation
• Disrupted hypothalamic-pituitary-ovarian axis — obesity alters the brain's hormonal signaling to the ovaries, further disrupting the already abnormal hormonal rhythms of PMOS and making regular ovulation even less likely

How PMOS Promotes Obesity:

The relationship runs powerfully in the other direction as well — PMOS actively promotes weight gain and makes weight loss extraordinarily difficult:

• Insulin resistance drives fat storage — elevated insulin levels promote fat accumulation, particularly in the abdomen, and make the body highly resistant to fat mobilization even with caloric restriction
• Hormonal dysregulation impairs metabolism — the abnormal androgen levels, disrupted estrogen-progesterone cycling, and altered adipokine profiles of PMOS collectively impair metabolic rate and fat oxidation
• Increased appetite and food cravings — insulin resistance and the hormonal dysregulation of PMOS drive increased hunger, particularly for carbohydrates and sugary foods, making dietary adherence extremely challenging
• Sleep disruption — the sleep apnea and poor sleep quality associated with PMOS raise ghrelin levels and lower leptin, further driving appetite and weight gain
• Depression and emotional eating — the psychological burden of PMOS frequently contributes to emotional eating patterns that perpetuate weight gain
• Exercise intolerance — fatigue, joint pain, sleep deprivation, and mood disorders make consistent physical activity difficult for many women with PMOS

The result is a cruel trap: PMOS makes weight gain more likely and weight loss dramatically harder, while excess weight makes every aspect of PMOS significantly worse. This is precisely why traditional diet and exercise approaches fail so frequently in women with PMOS — they are fighting against a powerful biological current — and why bariatric surgery can be such a genuinely life-changing intervention for these patients.

What Happens After Bariatric Surgery — The PMOS Transformation

The improvements in PMOS following bariatric surgery are among the most dramatic and multidimensional benefits I witness in my female patients. The changes are hormonal, metabolic, reproductive, psychological, and deeply personal — and they often begin remarkably quickly after surgery. Here is what the science and my clinical experience show:

Dramatic Improvement in Insulin Resistance

• Insulin resistance — the central metabolic driver of PMOS — improves profoundly and rapidly after bariatric surgery, often beginning within days of the procedure before significant weight loss has occurred
• Fasting insulin levels drop dramatically as the gut hormonal changes triggered by surgery directly improve insulin sensitivity
• As insulin levels normalize, the primary stimulus for excess androgen production by the ovaries is removed — triggering a cascade of hormonal improvements throughout the entire PMOS picture
• Improved insulin sensitivity also makes weight loss significantly easier going forward, breaking one of the most frustrating aspects of the obesity-PMOS cycle

Normalization of Androgens and Sex Hormones

• Studies consistently show significant reductions in testosterone and other androgen levels following bariatric surgery and weight loss
• Sex hormone binding globulin (SHBG) levels rise as liver function and metabolic health improve — binding more testosterone and reducing its biological activity throughout the body
• The ratio of LH to FSH — the pituitary hormones that drive the ovarian cycle and are characteristically abnormal in PMOS — normalizes in many patients after significant weight loss
• Estrogen levels rebalance as excess fat tissue — which converts androgens to estrogen through a process called aromatization — decreases
• These hormonal normalizations collectively create the conditions necessary for regular ovulation and menstrual cycling to resume

Restoration of Menstrual Regularity

• One of the most consistently reported and personally meaningful improvements my female PMOS patients describe after bariatric surgery is the return of regular menstrual periods
• Studies show that menstrual regularity improves in 80 to 90% of women with PMOS following bariatric surgery and significant weight loss
• Women who had irregular periods for years — or no periods at all — frequently experience the return of regular monthly cycles within months of surgery
• This restoration of menstrual regularity reflects genuine resumption of normal ovulatory function — not just a cosmetic hormonal change
• Regular ovulation dramatically reduces the risk of endometrial hyperplasia and cancer that results from the chronic unopposed estrogen exposure of anovulatory PMOS

Improved Fertility

• As insulin resistance improves, androgens normalize, and regular ovulation resumes, fertility improves dramatically in many women with PMOS after bariatric surgery
• Women who had struggled for years with infertility — some having undergone multiple rounds of fertility treatments without success — have gone on to conceive naturally after bariatric surgery
• The improvement in metabolic health also significantly reduces the risks associated with pregnancy in obese women with PMOS — including gestational diabetes, preeclampsia, and pregnancy loss
• As discussed previously, we recommend waiting 12 to 18 months after surgery before attempting pregnancy — to allow weight to stabilize and nutritional levels to be well established — but the fertility outlook after that window is dramatically improved for the majority of my patients

Improvement in Hirsutism and Acne

• The excess facial and body hair growth (hirsutism) and acne that cause so much distress and self-consciousness for women with PMOS are directly driven by elevated androgen levels
• As testosterone and other androgens normalize after surgery and weight loss, hirsutism and acne frequently improve significantly — though the timeline for hair changes is slower than other hormonal improvements, as hair follicles respond gradually over months to years
• Many of my patients describe the improvement in these visible manifestations of PMOS as enormously meaningful for their self-image, confidence, and quality of life

Improvement in Scalp Hair Loss

• Androgenic alopecia — the female pattern hair thinning driven by excess androgens in PMOS — can improve as androgen levels normalize after surgery
• It is important to note that some temporary hair shedding is normal in the first 3 to 6 months after bariatric surgery — a phenomenon called telogen effluvium, driven by the physiological stress of rapid weight loss and caloric restriction
• This temporary shedding is not permanent and resolves as weight stabilizes and nutritional status is optimized
• Long-term, the reduction in androgen levels after surgery is beneficial for scalp hair health in women with PMOS

Metabolic and Cardiovascular Benefits

• The metabolic syndrome that accompanies PMOS — high blood pressure, abnormal cholesterol, insulin resistance, and abdominal obesity — responds dramatically to bariatric surgery, as we have discussed in detail in previous sections
• The dramatically elevated lifetime risk of type 2 diabetes in PMOS patients is meaningfully reduced by the metabolic improvements following surgery
• Long-term cardiovascular risk — which is significantly elevated in women with PMOS — is reduced through improvements in blood pressure, cholesterol, blood sugar, and systemic inflammation
• Fatty liver disease — extremely common in PMOS patients — improves or resolves after surgery, as discussed previously

Psychological and Quality of Life Transformation

• The psychological burden of PMOS — depression, anxiety, body image distress, self-consciousness about hirsutism and acne, grief around infertility, and the frustration of failed weight loss attempts — is profound and often underappreciated by healthcare providers
• The improvements in hormonal health, physical appearance, fertility, metabolic function, and body weight that follow bariatric surgery frequently produce equally dramatic improvements in mental health and quality of life
• Many of my PMOS patients describe feeling — for the first time in their adult lives — like their body is finally working with them rather than against them
• The restoration of a sense of control over their health, hormones, and fertility is something that goes far beyond what any laboratory value or clinical outcome measure can capture

What the Research Shows

The scientific evidence supporting bariatric surgery as a transformative treatment for PMOS is robust and growing:

• A comprehensive systematic review examining PMOS outcomes after bariatric surgery found significant improvements in menstrual regularity, androgen levels, insulin resistance, and fertility across virtually all studies
• Studies show that testosterone levels decrease by 40 to 65% following bariatric surgery in women with PMOS — approaching or reaching normal levels in the majority of patients
• Menstrual regularity improves in 80 to 90% of patients with previously irregular cycles
• Insulin resistance improves dramatically — with fasting insulin levels and HOMA-IR scores normalizing in the majority of patients within the first year after surgery
• Multiple studies document spontaneous conception in women with PMOS who had previously failed fertility treatments, following bariatric surgery and weight loss
• The metabolic syndrome components associated with PMOS — elevated blood pressure, abnormal cholesterol, and high blood sugar — respond to bariatric surgery with the same dramatic improvements seen in non-PMOS obese patients
• Long-term studies show that these improvements are durable in patients who maintain their weight loss — with sustained hormonal normalization and metabolic health documented years after surgery

An Important Note — Fertility Returns Quickly

I want to make sure every woman of reproductive age reading this understands something critically important: fertility can return very quickly after bariatric surgery — sometimes within weeks of the procedure — as hormonal balance begins to restore. This catches many patients completely off guard.

Women who were told for years that they could not conceive because of PMOS, and who may not have been using contraception as a result, are suddenly at real risk of unintended pregnancy in the early postoperative period — which is precisely the wrong time to become pregnant, as the rapid weight loss and nutritional changes of the first year after surgery are not ideal conditions for a healthy pregnancy.

I counsel every female patient of reproductive age very explicitly before surgery: reliable contraception is essential starting immediately after bariatric surgery and continuing for the full 12 to 18 months of the rapid weight loss phase. Oral contraceptive pills are generally not the preferred method in the first year after surgery — particularly after malabsorptive procedures like gastric bypass — due to potentially impaired absorption. We discuss appropriate contraceptive options individually with each patient as part of their preoperative counseling.

What This Means for You

If you have PMOS and are considering bariatric surgery — or if you have obesity and have never been evaluated for PMOS — this information is profoundly important for your health, your hormones, and your future. PMOS is not something you simply have to live with and manage indefinitely. For women with PMOS and obesity, bariatric surgery offers the very real possibility of:

• Normalizing insulin resistance — the root metabolic driver of PMOS
• Dramatically reducing testosterone and androgen levels
• Restoring regular menstrual cycles
• Resuming normal ovulation and improving fertility
• Improving or resolving hirsutism and acne
• Reducing the long-term risks of diabetes, heart disease, and endometrial cancer
• Transforming metabolic health and quality of life in ways that years of dieting and medication management alone rarely achieve

Results vary depending on individual factors including the severity and duration of PMOS, the degree of insulin resistance, the specific procedure performed, and the amount of weight ultimately lost. However, meaningful improvement in PMOS symptoms and metabolic health is seen across virtually all patient groups — and for many women, the transformation is profound.

The bottom line: PMOS and obesity are locked in a mutually reinforcing cycle that traditional treatments struggle to break. Bariatric surgery interrupts that cycle at its roots — addressing the insulin resistance, hormonal dysregulation, and metabolic dysfunction that drive PMOS simultaneously and powerfully. For women with PMOS who have struggled with their weight, their hormones, their fertility, and their quality of life — bariatric surgery may offer something that no diet, medication, or lifestyle program alone can provide: a genuine fresh start. That conversation starts here, and I look forward to having it with you.